We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$6.17M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unisys
UIS
|
+$562K |
| 2 |
Fulgent Genetics
FLGT
|
+$385K |
| 3 |
Schrodinger
SDGR
|
+$384K |
| 4 |
Agilysys
AGYS
|
+$367K |
| 5 |
Riot Platforms
RIOT
|
+$344K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextDecade
NEXT
|
+$565K |
| 2 |
American Well
AMWL
|
+$535K |
| 3 |
iHeartMedia
IHRT
|
+$499K |
| 4 |
BRC Group Holdings
RILY
|
+$497K |
| 5 |
Lexicon Pharmaceuticals
LXRX
|
+$496K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.12% |
| 3 | Technology | 16.79% |
| 4 | Financials | 12.57% |
| 5 | Consumer Discretionary | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Verisk Analytics
VRSK
$26.4B
| $108K | 0.1% |
+459
| New | +$110K |
|
377
MannKind Corp
MNKD
$1.28B
| $108K | 0.1% |
23,809
+9,008
| +61% | +$35.4K |
|
|
ALEX
378
DELISTED
Alexander & Baldwin
ALEX
| $108K | 0.1% |
+6,537
| New | +$112K |
|
379
Revolution Medicines
RVMD
$40.2B
| $107K | 0.1% |
+3,335
| New | +$98.8K |
|
380
FirstCash
FCFS
$8.55B
| $107K | 0.1% |
841
+482
| +134% | +$55.9K |
|
381
Worthington Enterprises
WOR
$2.76B
| $107K | 0.1% |
1,723
+1,238
| +255% | +$73.7K |
|
382
Installed Building Products
IBP
$6.13B
| $107K | 0.1% |
414
+41
| +11% | +$8.79K |
|
383
Flowserve
FLS
$9.25B
| $107K | 0.1% |
2,339
-1,300
| -36% | -$54.7K |
|
384
MVB Financial
MVBF
$374M
| $107K | 0.1% |
+4,789
| New | +$104K |
|
|
HEPS
385
D-Market Electronic Services & Trading
HEPS
$1B
| $107K | 0.1% |
71,206
+65,963
| +1,258% | +$104K |
|
|
B
386
DELISTED
Barnes Group Inc.
B
| $107K | 0.1% |
+2,869
| New | +$98.7K |
|
387
BioMarin Pharmaceuticals
BMRN
$11.5B
| $106K | 0.1% |
+1,217
| New | +$109K |
|
388
CarGurus
CARG
$3.01B
| $106K | 0.1% |
4,596
+3,593
| +358% | +$83.1K |
|
|
MODN
389
DELISTED
MODEL N, INC.
MODN
| $106K | 0.1% |
3,723
+741
| +25% | +$19.6K |
|
390
Global Payments
GPN
$22.1B
| $106K | 0.1% |
+793
| New | +$105K |
|
391
Teradata
TDC
$2.68B
| $106K | 0.09% |
+2,734
| New | +$115K |
|
392
Larimar Therapeutics
LRMR
$416M
| $106K | 0.09% |
+13,927
| New | +$109K |
|
|
ORC
393
Orchid Island Capital
ORC
$1.31B
| $105K | 0.09% |
11,808
+5,958
| +102% | +$50.7K |
|
394
InvenTrust Properties
IVT
$2.84B
| $105K | 0.09% |
4,077
+3,669
| +899% | +$92.4K |
|
|
SVC
395
Service Properties Trust
SVC
$1.1B
| $105K | 0.09% |
3,083
+1,817
| +144% | +$67.4K |
|
396
Federal Signal
FSS
$7.25B
| $104K | 0.09% |
1,231
+1,065
| +642% | +$83.4K |
|
397
AMERISAFE
AMSF
$569M
| $104K | 0.09% |
2,082
+376
| +22% | +$18.7K |
|
398
Opendoor
OPEN
$3.69B
| $104K | 0.09% |
35,474
+20,667
| +140% | +$64.5K |
|
|
FBMS
399
DELISTED
The First Bancshares, Inc.
FBMS
| $103K | 0.09% |
+3,988
| New | +$102K |
|
|
LGTY
400
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $103K | 0.09% |
+9,027
| New | +$102K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2024 Portfolio in Review
As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.
EntryPoint Capital deployed $6.17M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.
- EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
- EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
- EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
- EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
- EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
- EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
- EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.
Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.